NovaBridge Biosciences Unrealized Gain (Loss) on Investments
NovaBridge Biosciences (NBP) reported Unrealized Gain (Loss) on Investments of -CNY 23.77 million for the 6-month period ending 2022-06-30, per its 6-K filed 2022-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2022-11-10
- 2022-06-30: Unrealized Gain (Loss) on Investments 6 month -23.77M CNY.
- 2021-06-30: Unrealized Gain (Loss) on Investments 6 month 13.49M CNY.
CNY
| Period end | Unrealized Gain (Loss) on Investments 6 month |
|---|---|
| 2022-06-30 | -23.77M CNY 6-K · filed 2022-11-10 |
| 2021-06-30 | 13.49M CNY 6-K · filed 2022-11-10 |
USD
| Period end | Unrealized Gain (Loss) on Investments 6 month |
|---|---|
| 2022-06-30 | -$3.55M 6-K · filed 2022-11-10 |